We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 06 MAY 2021
Is Dasatinib Dead? – An Incredible Change To The Plausibility Threshold
Gill Jennings & Every
It is just over four years since Board 3.3.01 of the EPO Boards of Appeal delivered its much-anticipated decision in the Dasatinib case (T 488/16).
United KingdomIntellectual Property







